# Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms

> **NCT07529483** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 35 (estimated)

## Conditions studied

- Pancreatic Cystic Neoplasm

## Interventions

- **PROCEDURE:** Ablation Therapy
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **OTHER:** Electronic Health Record Review
- **PROCEDURE:** Endoscopic Ultrasound
- **PROCEDURE:** Endoscopic Ultrasound-Guided Fine-Needle Aspiration
- **DRUG:** Gemcitabine Hydrochloride
- **PROCEDURE:** Magnetic Resonance Cholangiopancreatography
- **PROCEDURE:** Magnetic Resonance Imaging
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT07529483
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-12
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07529483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07529483, "Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07529483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*